Nuzenio

Gilead

Gilead news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 19 publisher sources 100/100 entity strength

Latest news

Should Gilead’s Swing to a Full‑Year Loss Outlook Require Action From Gilead Sciences (GILD) Investors? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:25:24 GMTEbola response turns to Merck vaccine, Gilead drug as Congo outbreak worsens - The Spokesman-ReviewThe Spokesman-Review · Sat, 08 Aug 2026 01:46:22 GMTPensionDanmark Pensionsforsikringsaktieselskab Purchases 25,515 Shares of Gilead Sciences, Inc. $GILD - MarketBeatMarketBeat · Fri, 07 Aug 2026 10:33:12 GMTNewEdge Advisors LLC Buys 231,715 Shares of Gilead Sciences, Inc. $GILD - MarketBeatMarketBeat · Fri, 07 Aug 2026 09:20:52 GMTHIV Progress in Kenya: Building the Bridge to Breakthrough - Gilead SciencesGilead Sciences · Fri, 07 Aug 2026 09:16:23 GMTGilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:32:35 GMTGilead reports strong Q2 driven by HIV portfolio - EMJEMJ · Thu, 06 Aug 2026 16:39:36 GMTMSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data - Clinical Trials ArenaClinical Trials Arena · Thu, 06 Aug 2026 10:25:17 GMT

Timeline

Sat, 08 Aug 2026 08:25:24 GMTShould Gilead’s Swing to a Full‑Year Loss Outlook Require Action From Gilead Sciences (GILD) Investors? - simplywall.st
Sat, 08 Aug 2026 01:46:22 GMTEbola response turns to Merck vaccine, Gilead drug as Congo outbreak worsens - The Spokesman-Review
Fri, 07 Aug 2026 10:33:12 GMTPensionDanmark Pensionsforsikringsaktieselskab Purchases 25,515 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Fri, 07 Aug 2026 09:20:52 GMTNewEdge Advisors LLC Buys 231,715 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Fri, 07 Aug 2026 09:16:23 GMTHIV Progress in Kenya: Building the Bridge to Breakthrough - Gilead Sciences
Fri, 07 Aug 2026 08:32:35 GMTGilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gilead.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

19 distinct publisher/source names are currently connected to this entity page.